Cindy Im
,
Credentials
PhD

Assistant Professor, Division of Pediatric Epidemiology & Clinical Research
Faculty, Department of Pediatrics
Associate Chair, Childhood Cancer Survivor Study (CCSS)
Member, Masonic Cancer Center
Epidemiology/Biostatistics Working Group
Member, St. Jude Lifetime Cohort Study (SJLIFE) Genomics/Genetics Working Group
Biography

Bio

Cindy Im, PhD, is an Assistant Professor in the Division of Epidemiology and Clinical Research in the Department of Pediatrics. She engages in multidisciplinary research that combines biological, epidemiological, and data sciences, with an emphasis on genetic epidemiology/statistical genetics methodology and cancer survivorship. She is currently leading a NIH-funded study to develop genetic risk scores that also account for the effects of cancer treatments (e.g., radiation therapy, specific chemotherapies), with the goal of improving prediction of second malignancies and cardiometabolic outcomes among long-term survivors of childhood cancer.

Education

PhD in Epidemiology, School of Public Health, University of Alberta Edmonton, AB, Canada

Fellowships, Residencies, and Visiting Engagements

MPH in Health Policy and Management,
Mailman School of Public Health, Columbia University
New York, New York, United States

Honors and Recognition

Assistant Professor Clinical/Translational Paper of the Year, Department of Pediatrics, University of Minnesota (2023, 2024)
Selected Publications

Selected Publications

Im C, Li N, Moon W, Liu Q, Morton LM, Leisenring WM, Howell RM, Chow EJ, Sklar CA, Wilson CL, Wang Z, Sapkota Y, Chemaitilly W, Ness KK, Hudson MM, Robison LL, Bhatia S, Armstrong GT, Yasui Y. Genome-wide association studies reveal novel locus with sex-/therapy-specific fracture risk effects in childhood cancer survivors. J Bone Miner Res. 2021 Apr;36(4):685-695.,
Im C, Qin N, Wang Z, Qiu W, Howell CR, Sapkota Y, Moon W, Chemaitilly W, Gibson TM, Mulrooney DA, Ness KK, Wilson CL, Morton LM, Armstrong GT, Bhatia S, Zhang J, Hudson MM, Robison LL, Yasui Y. Generalizability of “GWAS hits” in clinical populations: Lessons from childhood cancer survivors. Amer J Hum Genet. 2020 Oct 1;107(4):636-53.,
Im C, Yuan Y, Austin ED, Stokes DC, Krasin MJ, Davidoff AM, Sapkota Y, Wang Z, Ness KK, Wilson CL, Armstrong GT, Hudson MM, Robison LL, Mulrooney DA, Yasui Y. Leveraging Therapy-Specific Polygenic Risk Scores to Predict Restrictive Lung Defects in Childhood Cancer Survivors. Cancer Res. 2022 Aug 16;82(16):2940-2950.,
Contact

Contact

Address

D529-3B Mayo
420 Delaware St. SE
Minneapolis, MN 55455